These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26256896)

  • 21. The Degree of Hyperglycemia Excursion in Patients of Kidney Transplantation (KT) or Liver Transplantation (LT) Assessed by Continuous Glucose Monitoring (CGM): Pilot Study.
    Jin HY; Lee KA; Kim YJ; Park TS; Lee S; Park SK; Hwang HP; Yang JD; Ahn SW; Yu HC
    J Diabetes Res; 2019; 2019():1757182. PubMed ID: 31886275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Perioperative Hyperglycemia or Glucose Variability and Postoperative Acute Kidney Injury After Liver Transplantation: A Retrospective Observational Study.
    Yoo S; Lee HJ; Lee H; Ryu HG
    Anesth Analg; 2017 Jan; 124(1):35-41. PubMed ID: 27749341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Rifaximin Therapy on Ischemia/Reperfusion Injury in Liver Transplantation: A Propensity Score-Matched Analysis.
    Ito T; Nakamura K; Kageyama S; Korayem IM; Hirao H; Kadono K; Aziz J; Younan S; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
    Liver Transpl; 2019 Dec; 25(12):1778-1789. PubMed ID: 31509643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longterm results of liver transplantation from donation after circulatory death.
    Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
    Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study.
    D'Errico A; Riefolo M; Serenari M; De Pace V; Santandrea G; Monica M; de Cillia C; Ravaioli M; Cescon M; Vasuri F;
    Dig Liver Dis; 2020 Feb; 52(2):185-189. PubMed ID: 31155489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.
    Yang L; Xin EY; Liao B; Lai LJ; Han M; Wang XP; Ju WQ; Wang DP; Guo ZY; He XS
    Transplant Proc; 2017; 49(6):1357-1363. PubMed ID: 28736007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical relevance of the anhepatic phase during liver transplantation.
    Ijtsma AJ; van der Hilst CS; de Boer MT; de Jong KP; Peeters PM; Porte RJ; Slooff MJ
    Liver Transpl; 2009 Sep; 15(9):1050-5. PubMed ID: 19718649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive Role of Intraoperative Serum Brain Natriuretic Peptide for Early Allograft Dysfunction in Living Donor Liver Transplantation.
    Chae MS; Koo JM; Park CS
    Ann Transplant; 2016 Aug; 21():538-49. PubMed ID: 27572618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.
    Martini S; Tandoi F; Terzi di Bergamo L; Strona S; Lavezzo B; Sacco M; Maione F; Gonella F; Strignano P; Dell Olio D; Salizzoni M; Saracco GM; Romagnoli R
    Liver Transpl; 2017 Jul; 23(7):915-924. PubMed ID: 28422425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.
    Kollmann D; Sapisochin G; Goldaracena N; Hansen BE; Rajakumar R; Selzner N; Bhat M; McCluskey S; Cattral MS; Greig PD; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M
    Liver Transpl; 2018 Jun; 24(6):779-789. PubMed ID: 29604237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor Hepatic Occult Collagen Deposition Predisposes to Peritransplant Stress and Impacts Human Liver Transplantation.
    Hirao H; Ito T; Kadono K; Kojima H; Naini BV; Nakamura K; Kageyama S; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
    Hepatology; 2021 Nov; 74(5):2759-2773. PubMed ID: 34170562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischemic Postconditioning of the Liver Graft in Adult Liver Transplantation.
    Ricca L; Lemoine A; Cauchy F; Hamelin J; Sebagh M; Esposti DD; Salloum C; Vibert E; Balducci G; Azoulay D
    Transplantation; 2015 Aug; 99(8):1633-43. PubMed ID: 25856406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the Predictive Ability for Graft Loss and Mortality of Two Criteria for Early Allograft Dysfunction After Liver Transplantation.
    Brea-Gómez E; Villar-Quintana R; Plata-Illescas C; Zambudio-Carroll N; Lopez-Garrido MA; Nogueras-Lopez F; Muffak-Granero K; Becerra-Massare A; Villegas-Herrera MT; Segura Jiménez I; Muñoz Pérez N; Villar-Del-Moral JM
    Transplant Proc; 2018 Mar; 50(2):605-609. PubMed ID: 29579865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor hypernatremia before procurement and early outcomes following pediatric liver transplantation.
    Kaseje N; McLin V; Toso C; Poncet A; Wildhaber BE
    Liver Transpl; 2015 Aug; 21(8):1076-81. PubMed ID: 25902852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor liver apoptosis is associated with early allograft dysfunction and decreased short-term graft survival after liver transplantation.
    Zhu Z; Tang Y; Huang S; Zhao Q; Schroder PM; Zhang Z; Zhang Y; Sun C; Wang L; Ju W; Wang D; Guo Z; He X
    Clin Transplant; 2018 Dec; 32(12):e13438. PubMed ID: 30383902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Townsend SA; Monga MA; Nightingale P; Mutimer D; Elsharkawy AM; Holt A
    Transplant Proc; 2017 Nov; 49(9):2129-2134. PubMed ID: 29149973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Outcomes of Liver Transplantation Using Donors After Circulatory Death in Patients With Hepatocellular Carcinoma: A Comparative Study.
    Martinez-Insfran LA; Ramirez P; Cascales P; Alconchel F; Ferreras D; Febrero B; Martinez M; González MR; Sanchez-Bueno F; Robles R; Parrilla P
    Transplant Proc; 2019 Mar; 51(2):359-364. PubMed ID: 30879541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts.
    Hernandez-Alejandro R; Croome KP; Quan D; Mawardi M; Chandok N; Dale C; McAlister V; Levstik MA; Wall W; Marotta P
    Transplantation; 2011 Sep; 92(6):686-9. PubMed ID: 21832962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.